CODE OF CONDUCT

Operational Partner Code

Version 1.0 · Effective 2026-02-01

This code extends the Ethics Charter v1.0 — the 7 charter clauses are the moral foundation; this document describes how they apply in practice.

1. Scope and applicability

This Code of Conduct applies to all approved Nutramilo partners (Bronze → Founding) and Clinical Advisory Partners.
Partnership starts on the date the application is approved and the Ethics Charter v1.0+ is accepted.
The code is reviewed annually; changes are communicated 30 days in advance via email.

All content must be scientifically supported. PMID/DOI citations are required for medical claims.
Do not publish content that misleads about Nutramilo's efficacy in treating disease.
Use official NIS™/DIL™/Nutramilo™ branding per guidelines (no logo modifications).
When sharing plate analyses → always include DOI 10.5281/zenodo.20571802 for reproducibility.
Avoid sensationalist headlines ('This pill will save you from diabetes').

FTC-style disclosure required on every promotional post (#partner, #ad, 'In partnership with @nutramilo').
Discount codes / affiliate links require visible disclosure in the first 3 lines.
Email / blog signature must include partner role: 'Bronze/Silver/Gold/Founding Ambassador, Nutramilo'.
When speaking publicly (webinar / podcast) — verbal disclosure in the first 60 seconds.

NEVER share identifiable patient information without written informed consent.
Case studies / testimonials require a signed release form (template via partners@nutramilo.com).
Protect your own Nutramilo account credentials. Do not share login details.
Report security incidents within 24 hours (security@nutramilo.com).

No harassment, discrimination, or hate speech against patients, colleagues, or the community.
No public attacks on competing products or their employees.
Constructive criticism of Nutramilo is welcome — email partners@nutramilo.com, not publicly.
Comply with your local professional codes of ethics (BMA, ICN, NCA, and equivalents for your profession).

Declare all material COI: editorial board roles, pharma consulting, speakers bureaus, equity holdings.
Advisory Partners must complete a full COI declaration before the first Board meeting.
Update your COI declaration within 30 days of any material change (new consulting role, etc.).
In case of direct competition (work for a competing metabolic-health stack) immediate disclosure is required.

Step 1 (private warning): the violation is documented; the partner receives an email with corrective action.
Step 2 (probation): a 30-day probation period; benefits temporarily suspended; mandatory review meeting.
Step 3 (termination): partnership is terminated; referral code deactivated; outstanding revenue is paid pro-rata.
Right of appeal within 14 days to ethics@nutramilo.com — independent review by a 2-member Ethics Committee.
Criminal conduct or massive privacy breach → immediate termination without the warning sequence.

Conflicts between partners: first attempt direct resolution (15 days).
If unresolved → file a formal complaint at ethics@nutramilo.com with documentation.
The Ethics Committee reviews within 21 days and issues a binding decision.
Decisions are published anonymised in the /science/governance directory (transparency).

Have a question or want to report a violation? Email ethics@nutramilo.com — the Ethics Committee reviews every report within 21 days.

Nutramilo is a wellness and educational platform — NOT a medical deviceLimitations Dental Risk Breast Health Policies Complaint → CPDP EU↔US transfer